HORIBA develops IRLAM™ technology to bring new value in gas analysis with the first four products equipped with IRLAM technology

07/29/2021 |   Press Release HORIBA, Ltd. (hereinafter referred to as “HORIBA”) today announced that it has developed an innovative proprietary gas analysis technology called InfraRed Laser Absorption Modulation (IRLAM™*1) and will launch four new products on July 29th as the first products equipped with this technology. IRLAM, a new infrared gas measurement technology invented by HORIBA, utilizes... Read more

Data for Roche’s Evrysdi® (risdiplam) published in New England Journal of Medicine shows significant improvement in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)

FIREFISH Part 2 study showed treatment with Evrysdi helped babies stay free of permanent ventilation, sit without support and improve across a range of motor milestones Evrysdi has proven efficacy in adults, children and babies two months and older with over 4,000 patients treated to date SMA is the leading genetic cause of death in... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted restricted stock units (“RSUs”) covering 29,500 shares of Pacific Biosciences common stock, to a... Read more

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

New data for Roche’s Hemlibra reinforce safety profile in people with haemophilia A

Final analysis from the phase IIIb STASEY study, including data from 193 people with haemophilia A, further support the benefit/risk profile of Hemlibra, with no new safety signals identified1 STASEY is one of the largest open-label studies primarily assessing safety and tolerability of a medicine for people with haemophilia A with factor VIII inhibitors Hemlibra... Read more

SPECTRO Introduces SPECTROMAXx LMX09 ARC/SPARK OES Analyzer

July 15, 2021 SPECTRO Analytical Instruments has announced the newest version of its SPECTROMAXx ARC/SPARK OES analyzer with next-generation improvements for the ultra-reliable advanced analysis of incoming and outgoing materials at metal producing and fabricating plants. Perhaps the industry’s best-selling OES analyzers, SPECTROMAXx instruments are a critical element of supply chains worldwide.  The introduction of... Read more

Researchers Achieve Extraordinary Spatial Resolution for In-situ Atomic Resolution TEM Using New Luminary Micro Technique

Materials science researchers in Japan have achieved extraordinary in-situ Transmission Electron Microscope (TEM) experiments using a new Luminary Micro laser technique. They succeeded in recording atomic-resolution in-situ movies of growing carbon nanotubes and onion-shaped carbon nano structures. The structures were formed by laser irradiation of samples made of carbon films and iron nanoparticles. This experiment... Read more

10x Genomics Introduces New Chromium X Series for Single Cell Analysis

July 14, 2021 at 8:01 AM EDTPDF Version Million-Cell Experiments Routinely Accessible for the First Time PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.... Read more

BD Launches Reimagined Digital Marketplace for Flow Cytometry

FRANKLIN LAKES, N.J., July 7, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new bdbiosciences.com web and eCommerce site, an entirely “reimagined” digital marketplace designed to provide an enhanced online purchasing experience for users and their procurement teams. The new BD... Read more